From the publisher feed
Food and Drug Administration nominee Dr. Heidi Overton committed to a timeline for a delayed mifepristone safety study, Sen. Josh Hawley's office says.
Read the original at Fox News ↗Opens the original publisher page. Access, copyright and subscriptions are controlled by the publisher.
A useful next step
- Read the short publisher description here.
- Open the full report directly at the publisher.
- Compare this topic with other sources when useful.